Article feature image

Cognition Therapeutics: Targeting S2R For Age-Related Degenerative Diseases

Stock Analysis

Chunumunu/iStock via Getty Images
About
Cognition Therapeutics, Inc. (CGTX) is a clinical-stage biopharmaceutical company developing small molecule therapeutics for age-related degenerative diseases and disorders of the central nervous system ((CNS)) and…

Click here to view the original article.

Tags:
,
Facebook Google+ Twitter Pinterest

Related Posts